BRISBANE: ResAppHealth Limited and Australia’s leading virtual super clinic Phenix Health Pty Ltd announced that ResAppDx-EU, the world’s first clinically validated and regulatory-approved respiratory disease diagnostic test, is scheduled to be available on the Phenix Telehealth app on Monday the 6th of July.
Phenix and ResApp signed a software licensing agreement in June to provide ResAppDx-EU in the Phenix Telehealth app. The software licensing agreement is a two-year, non-exclusive agreement, with a per test license fee received by ResApp within the previously targeted range of $5-10.
The software integration has been completed and the updated Phenix Telehealth app, which includes the ResAppDx-EU test, has been submitted to the App Store for review and is planned to be released to the public on Monday the 6th of July.
ResAppDx-EU is directly integrated into the Phenix Telehealth app and uses the patient’s own smartphone to record and analyse the patient’s cough sounds. The results are securely sent to their telehealth doctor. ResAppDx-EU does not require the purchase or use of any accessories or additional hardware devices.
“The launch of our virtual respiratory clinic means we are able to offer patients who have respiratory symptoms a complete care experience,” said Gillian Alexis, CEO and founder of Phenix.
“With ResApp’s technology now integrated into the Phenix Teleheath app, our doctors can remotely assess patients with confidence, perform a high quality video consultation and even deliver medications to their patient’s home.”
“We’re excited to be launching ResAppDx-EU Australia-wide through Phenix’s virtual respiratory clinics,” said Tony Keating, CEO and Managing Director of ResApp. “After the Australian government approved Medicare rebates for telehealth consultations, adoption of telehealth in Australia has accelerated. The combination of Phenix’s virtual consultation platform and ResAppDx-EU enables clinicians to accurately assess patients with respiratory symptoms, delivering the high levels of care that patients expect.”